Bensen Daniel 4
4 · Tyra Biosciences, Inc. · Filed Nov 17, 2025
Insider Transaction Report
Form 4
Bensen Daniel
Chief Discovery Officer
Transactions
- Sale
Common Stock
2025-11-13$16.00/sh−1,111$17,780→ 426,870 total - Sale
Common Stock
2025-11-14$16.02/sh−110,228$1,765,489→ 316,642 total - Sale
Common Stock
2025-11-17$16.11/sh−18,572$299,191→ 298,070 total - Sale
Common Stock
2025-11-17$17.07/sh−1,500$25,607→ 296,570 total
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.02. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.13. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $17.00. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F5]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.06 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.